Bonding plastics to metals in a medical device isn’t just a mechanical problem — it’s a regulatory one too, and getting both right at the same time is where a lot of adhesive selection processes go wrong.
The Medical Device Bonding Challenge: Biocompatibility and Substrate Versatility
As devices become more intricate — combining hard plastics like ABS or polycarbonate with metals like stainless steel or aluminum in small, high-precision assemblies — manufacturers need an adhesive that bridges those materials reliably. The ideal choice satisfies several criteria at once: biocompatibility confirmed against ISO 10993-5 cytotoxicity testing, high bond strength capable of withstanding operational stress and vibration, thermal and chemical resistance through sterilization cycles like EtO, gamma, E-beam, or autoclave, and substrate versatility across both low-surface-energy plastics and passive metals with minimal surface preparation.
The Solution: High-Performance Medical Cyanoacrylates
Cyanoacrylates are the standard chemistry for high-speed assembly and small-area bonding in medical devices, but standard-grade CAs often lack the thermal stability or flexibility that demanding plastic-metal bonds need, especially where thermal shock from sterilization is involved. Incure’s Cyro-Weld™ medical cyanoacrylate line is formulated specifically to address that gap, with multiple grades tested to meet ISO 10993-5.
Recommended Product: Incure Cyro-Weld™ CM-500
For a durable bond between plastics and metals in medical device assemblies, Cyro-Weld™ CM-500 is formulated around thermal resilience and multi-substrate strength.
- Rubber-toughened formulation: Improves resistance to thermal shock, peel, and impact — important where a plastic and a metal component expand at different rates under thermal load.
- Elevated-temperature stability: Engineered to resist the operating and sterilization temperatures that can degrade standard-grade cyanoacrylates over time.
- Medium viscosity (400–600 cP): A versatile, non-wicking viscosity that supports reliable gap-filling and controlled dispensing on vertical or angled surfaces.
- Clear cure: The cured adhesive is colorless and transparent, which matters for visually inspected or patient-facing components.
- ISO 10993-5 compliance: Formulated to meet the cytotoxicity standard, supporting the material-qualification portion of a broader regulatory submission.
Key Benefits for Industrial Medical Device Manufacturers
Selecting a rubber-toughened medical CA like CM-500 delivers faster throughput through fast fixture time, reduced rework thanks to better adhesion and thermal-shock resistance, simplified procurement by covering plastics, metals, and rubber with a single product, and a documented ISO 10993-5 testing trail that supports material qualification.
Requesting Technical Support
Sterilization compatibility always needs validation at the device level rather than being assumed from a datasheet. To request technical data or discuss testing scope for your specific plastic-metal assembly, Email Us.
Understanding Why These Bonds Fail Without the Right Chemistry
The root cause behind most plastic-to-metal bond failures isn’t inadequate adhesive strength — it’s the differential thermal expansion between the two materials working the bondline over repeated cycles, a mechanism explained in detail in our guide to how CTE mismatch causes adhesive bond failure. For manufacturers evaluating adhesive chemistries for high-temperature-service applications more broadly, our guide to Epo-Weld™ HECC ceramic coatings covers a related but distinct part of Incure’s product line, and our comparison of UV glue versus epoxy for heavy-duty repairs is a useful reference for cure-speed trade-offs.
Frequently Asked Questions
Q: Does ISO 10993-5 testing alone qualify CM-500 for any patient-contact device?
A: No — ISO 10993-5 cytotoxicity testing is one component of a broader biocompatibility evaluation. Depending on contact duration and type, additional testing such as sensitization or irritation studies may be required at the device level.
Q: Why is clarity specified as a feature for a structural adhesive?
A: In plastic-to-metal assemblies with visual or automated inspection steps, a clear cured bondline makes voids, bubbles, or incomplete fill visually detectable, which supports tighter quality control than an opaque adhesive would.
Q: How does CM-500 compare to a standard-grade cyanoacrylate on cost-sensitive, high-volume programs?
A: While a standard-grade CA may look attractive on unit cost, its lower thermal and impact resistance often shows up later as field returns or rework in medical applications — the rubber-toughened, thermally stable chemistry in CM-500 is built to avoid that trade-off.
Q: Is surface roughening ever needed on the metal side of a CM-500 bond?
A: Generally not — CM-500 is formulated to adhere well to passive metal surfaces like stainless steel and aluminum without mechanical abrasion, though removing oils, oxidation, or mold-release residue beforehand remains important for consistent results.
Q: Does the ISO 10993-5 testing on CM-500 need to be repeated if a manufacturer changes the plastic substrate it’s bonded to?
A: The adhesive’s own cytotoxicity testing doesn’t change, but the finished device’s overall biocompatibility qualification should still account for the specific plastic-metal-adhesive combination used, since regulatory submissions evaluate the assembled device, not the adhesive in isolation.
Ready to optimize your plastic-to-metal bonding process for a biocompatible, regulatory-ready device? Contact Our Team to request technical support and integrate Cyro-Weld™ CM-500 into your manufacturing process.
Visit www.incurelab.com for more information.